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INTRODUCTION
Paraquat (1,1′ -dimethyl-4, 4′ -bipyridium dichloride) was
introduced in 1962 as an effective herbicide that had low chron-
ic toxicity because of its rapid deactivation upon soil contact
(1). However, it has become notorious worldwide as a potent
human poison. Despite the continuing decrease in the agri-
cultural population, the incidence rate of paraquat poisoning
is rapidly increasing in Korea with hundreds of deaths from
this herbicide every year (2). In humans, intentional or acci-
dental ingestion of paraquat is frequently fatal due to the fail-
ure of multiple organs (3). Early mortality of patients suffering
from paraquat poisoning occurs as a result of vascular collapse,
while delayed mortality is mainly due to lung damage.
Injury to pneumocytes is initiated by the nicotinamide ade-
nine dinucleotide phosphate (NADPH)-dependent reduction
of paraquat to monocation radicals (PQ+). Spontaneous reaction
with molecular oxygen yields the superoxide radical (O2
-) and
reforms the paraquat dication, which can be reduced again.
This process, known as a redox cycle, is sustained by the exten-
sive supply of electrons and oxygen in the lungs (4). Dismu-
tation of the superoxide species, which is catalyzed by super-
oxide dismutases (SOD), leads to the formation of hydrogen
peroxide. This can in turn be metabolized to water by cata-
lases or peroxidases. Superoxide and hydrogen peroxide also
undergo a series of iron-catalyzed reactions to yield hydroxyl
free radicals (OH
-). These are highly toxic themselves and can
also generate more free radicals by reaction with other biomo-
lecules, such as proteins or membrane fatty acids (5).
In contrast to the rapid production of toxic oxygen species,
the capacity of antioxidant systems, such as the enzyme SOD,
catalase, glutathione (GSH) peroxidase, and vitamins C and
E, is limited, and there is a lag time in their adaptation. This
imbalance explains why the dose-response curve for paraquat
toxicity is very steep (6).
Over the past 30 yr, several methods have been used in
attempts to modify the toxicity of paraquat: (a) prevention
of absorption from the gastrointestinal tract (7), (b) removal
from the bloodstream (8, 9), (c) prevention of accumulation
in the lung (10), (d) scavenging of oxygen free radicals (11),
and (e) prevention of lung fibrosis (12). Unfortunately, all of
these methods have not been proven effective, with the out-
come being already determined by the degree of exposure at
the time of the arrival of a patient at the clinic. The medical
action taken immediately upon arrival is crucial, as is a multi-
disciplinary approach to assisting with impending death in
the event that it is inevitable.
Recently, Suntres (13) presented an excellent review on the
status of antioxidants in ameliorating or treating the toxic
effects produced by paraquat. A number of sulfhydryl com-
pounds have been examined based on their antioxidant ability.
An early observation by Bus et al. (14) was that depletion of
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Effects of N-acetyl-L-cysteine and Glutathione on Antioxidant Status
of Human Serum and 3T3 Fibroblasts
The effectiveness of several sulfhydryl compounds in the treatment of paraquat
intoxication has been previously tested based on their antioxidant ability. However,
practical guidelines for their clinical use remain to be determined. As a preliminary
pharmacokinetic study on sulfhydryl compounds, we attempted to establish the
optimal concentration of N-acetyl-L-cysteine, glutathione, superoxide dismutase,
and catalase. We measured the antioxidant effect of these antioxidants in normal
pooled plasma and on intracellular reactive oxygen species (ROS) induced by
paraquat. N-acetyl-L-cysteine begins to suppress the production of ROS in plas-
ma at concentrations as low as 5 mM, with the suppression being maximal at 40
mM. In the same way, glutathione increased the total antioxidant status in plasma
at concentrations of 5-40 mM in a dose-dependent manner. Complete suppression
of ROS in plasma induced by exposure to 500  M paraquat for 40 min was ob-
served when using 40 mM N-acetyl-L-cysteine and 5 mM glutathione. These con-
centrations are comparable with 50 units of catalase, which reduced ROS at con-
centrations of 5-100 units. Further pharmacokinetic study into the systemic admin-
istration of these antioxidants is necessary, using effective concentrations of 5-40
mM for both N-acetyl-L-cysteine and glutathione, and 1-50 units of catalase.
Key Words : Antioxidants; Glutathione; Acetylcysteine; Paraquat; Poisoning
Received : 24 March 2003
Accepted : 3 June 2003650 S.-Y. Hong, J.-O. Yang, E.-Y. Lee, et al.
GSH enhanced paraquat toxicity. Hagen et al. (15) and Brown
et al. (16) showed that the addition of GSH to type-II alveo-
lar cells protected against paraquat toxicity. Furthermore, the
evidence that GSH peroxidase plays a key role in protecting
animals against paraquat toxicity has been shown in recent
studies on transgenic mice in which deletion of this enzyme
enhances toxicity while addition of it affords some protec-
tion (17).
GSH provides the reducing equivalent for the reduction of
hydrogen peroxide to H2O, and is oxidized to its disulfide
(GSSG). Most of the GSSG is immediately reduced back to
GSH through a GSH reductase with the cofactor NADPH.
In the liver, GSSG is secreted mainly into bile, while in the
heart and lungs it is released mainly into the perfusate of these
organs (18).
N-acetyl-L-cysteine (NAC) is a precursor of GSH. Hoffer
et al. (19) incubated NAC with type-II alveolar cells, and
showed enhanced GSH content and prevention of paraquat-
induced cytotoxicity. Moreover, it is used clinically for a broad
spectrum of indications including mucolysis, detoxification
after acetaminophen poisoning, adult respiratory distress syn-
drome, hyperoxia-induced pulmonary damage, HIV infection,
cancer, and heart disease (20-22).
However, despite their frequent use and the considerable
amount of clinical knowledge on these drugs, many questions
still remain to be answered, including: What is the therapeutic
window of the blood concentration of these drugs? What is
the best antioxidant among the thiol compounds? Are they
effective antioxidants for both intracellular reactive oxygen
species (ROS) and/or ROS formed in plasma?
In general, safe and effective drug therapy requires adequate
delivery to their molecular targets in tissues at concentrations
within the range that yields efficacy without toxicity. The pur-
pose of this study was to establish the optimal concentrations
of NAC, GSH, SOD, and catalase as a precursor to the phar-
macokinetic study of sulfhydryl compounds for systemic ad-
ministration in patients with acute paraquat intoxication.
MATERIALS AND METHODS
Study Design
This study consisted of two experimental designs. First, we
measured the antioxidant effects of NAC, GSH, SOD, and
catalase which were purchased from Sigma (St. Louis, Mis-
souri, U.S.A.), in normal pooled plasma (NPP). Second, we
measured the antioxidant effects of NAC, GSH, SOD, and
catalase on the intracellular ROS induced by paraquat.
Normal Pooled Plasma and Basal Vitamin C Level
NPP was collected from 20 Koreans (10 males and 10 fe-
males) aged between 25 and 55 yr who had visited Soonchun-
hyang University Cheonan Hospital (Cheonan, Korea) for a
medical examination. They had taken regular diet for 1 week
prior to the examination. None of the subjects were alcoholics,
and none had taken supplemental vitamins within 2 weeks
of the study. Blood chemistry was measured by an automatic
analyzer, and the results were as follows: total protein, 7.8
mg/dL; albumin, 4.6 mg/dL; fasting glucose, 93.9 mg/dL;
total bilirubin, 1.0 mg/dL; blood urea nitrogen, 14.5 mg/dL;
creatinine, 0.9 mg/dL; uric acid, 5.5 mg/dL; cholesterol, 171.1
mg/dL; and triglyceride, 97.8 mg/dL.
The concentration of vitamin C, as measured using a pho-
tometric method, was 0.48 mg/dL in NPP. The principle of
this method is that the ascorbic acid in plasma is oxidized by
Cu2+ to form dehydroascorbic acid, which reacts with acidic
2, 4-dinitrophenylhydrazine to form a red bis-hydrazine, whose
fluorescence is measured at 520 nm.
Total antioxidant status (TAS) in the NPP was measured
using a commercial kit (BTS
�, Randox Laboratories, U.K.) and
a biochemical autoanalyzer (model 7150, Hitachi, Tokyo) ac-
cording to the manufacturer’s instruction. The principle of
TAS measurement is based on the quenching of the ABTS
�
[2,2′ -azino-di-(3-ethylbenzthiazoline sulphonate)] radical
cation, which is produced by the interaction of ABTS
� with
ferryl myoglobin radical species generated by the activation
on metmyoglobin with H2O2 (23). The intra- and inter-assay
coefficients of variation for this method were 7.5% and 8.7%,
respectively. TAS was measured in NPP after addition of
0.1-100 mM NAC and GSH, and 0.1-100 unit/mL of both
catalase and SOD. All samples were incubated for 30 min at
37℃before assay. The results were expressed as the percentage
of TAS of NPP, where the basal TAS level of NPP was 1.2
mM/L. Tests for TAS were duplicated and the results are
expressed as a mean value.
Cell Culture
Swiss 3T3 fibroblasts obtained from American Type Culture
Collection (ATCC CCL 92) were maintained at 37℃in Dul-
becco’s modified Eagle’s medium supplemented with 25 mM
HEPES, pH 7.4, 10% (v/v) fetal bovine serum, 100 unit/mL
penicillin, and 100 mg/mL streptomycin (culture medium).
For experiments, cells were cultured on round coverslips in
12-well plates and then stabilized for 30 min with Dulbecco’s
modified Eagle’s medium supplemented with 5 mg/mL apo-
transferrin, 1 mg/mL bovine serum albumin, 25 mM HEPES
(pH 7.4), 2 mM glutamine, 100 unit/mL penicillin, and 100
mg/mL streptomycin (serum-free medium).
Measurement of Intracellular ROS
Intracellular ROS was measured at a paraquat concentration
of 500  M after the incubation period of 40 min at various
concentrations of catalase, SOD, NAC, or GSH. For the last
5 min of stimulation, 5  M H2DCFDA was added to enablemeasurement of intracellular ROS.
The amount of intracellular ROS was measured according
to the procedures of Koo et al. (24). Cultured cells on round
coverslips were stabilized in serum-free medium without phe-
nol red for at least 30 min and stimulated with paraquat for
varying periods of time. Sometimes, cells were preincubated
with NAC or catalase for 30 min. ROS generation in cells was
assessed using the probe 2, 7-dichlorofluorescein (DCF; Molec-
ular Probes, U.S.A.). For the last 5 min of stimulation, the
membrane-permeable diacetate form of the dye (reduced DCF:
DCFH-diacetate) was added to the perfusate at a final con-
centration of 5  M. Within the cell, esterases cleave the acetate
groups on DCFH-diacetate, thus trapping the reduced probe
(DCFH) intracellularly. ROS in the cells oxidize DCFH, yield-
ing the fluorescent product DCF. Intensity values are reported
relative to the initial values, after subtracting the background.
Then, the cells were immediately observed by a laser scanning
confocal microscope (model LSM410, Carl Zeiss, Germany).
The samples were excited by a 488 nm argon laser, and images
were filtered by a long-pass filter with a cutoff wavelength
of 515 nm.
In our preliminary study, paraquat produced ROS in Swiss
3T3 fibroblasts at concentrations of 50-500  M in a dose-de-
pendent manner at 30-60 min. The cells remained alive when
the paraquat concentration was less than 500  M. However,
they detached within 30 min when the paraquat concentra-
tion was over 600  M or when the incubation time was over
60 min at lower concentrations. Therefore, we selected the op-
timal condition for our experiments to be 500  M for 40 min.
Statistical Analysis
Results were expressed as mean±SD unless stated other-
wise. Intracellular ROS was measured in about 30 cells ran-
domly selected from three separate experiments, and DCF
fluorescence intensities of treated cells were compared with
those of untreated control cells. Student’s t-test was used to
detect differences in ROS between groups. Statistical signif-
icance was defined as probability values of p<0.05.
RESULTS
Effects of NAC and GSH on the Production of ROS in
NPP
NAC begin to suppress the production of ROS at a concen-
tration of 5 mM, with the suppression being maximal at 40
mM. There was a dose-dependent relation between TAS
and NAC as follows: 106.0% at 5 mM, 110.0% at 10 mM,
112.0% at 20 mM, and 118.0% at 40 mM. However, the
level of TAS was flat when the concentration of NAC was
over 40 mM (Fig. 1).
In the same way, GSH increased TAS for concentrations
of 5-40 mM in a dose-dependent manner. But the slope of the
dose dependency was greater for GSH than for NAC: 107.0 %
at 5 mM, 115.3% at 10 mM, 121.0% at 20 mM, and 141.6%
at 40 mM. As for NAC, the level of TAS was flat for GSH
concentrations over 40 mM (Fig. 1). Catalase was observed to
affect the production of ROS for concentrations from 0.5 unit/
mL (106.5%) to 1 unit/mL (112.0%), with the effect being
flat for catalase concentrations over 1 unit/mL. SOD at con-
centrations of 0.1-100 unit/mL did not affect the TAS of
NPP (Fig. 1).
Effects of NAC and GSH on the Paraquat-induced
ROS Production in Swiss 3T3 Fibroblasts
ROS was produced by paraquat at concentrations between
20-500  M, for 40 min incubation (Fig. 2). The production
of ROS is dependent on the paraquat concentration. The cells
detached within 30 min when the paraquat concentration over
600  M or an incubation time of over 60 min regardless of
the concentration. NAC at 5-40 mM and GSH at 1-10 mM
suppressed ROS in a dose-dependent manner (Fig. 3), with
complete suppression of ROS being observed for 40 mM NAC
and 5 mM GSH. These concentrations were comparable with
50 unit/mL of catalase, which reduced intracellular ROS at
concentrations of 5-100 unit/mL in a dose-dependent manner
(Fig. 4). SOD at concentrations of 0.1-100 unit/mL did not
affect intracellular ROS.
DISCUSSION
The assessment of oxidant stress is complicated by the lack
of universal oxidant stress products or markers. However, the
Antioxidants in Paraquat Poisoning 651
Fig. 1. Antioxidant capacity in plasma: Total antioxidant capacity
(TAS) was measured on normal pooled plasma (NPP) after addi-
tion of N-acetyl-cysteine (NAC), glutathione (GSH), catalase or SOD.
The X axis represents log scales of concentrations for NAC, GSH
(mM), catalase or SOD (unit/mL). The Y axis represents TAS (%)
of NPP.
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Fig. 4. Effect of catalase on the production of ROS by PQ in Swiss
3T3: 5-100 unit/mL of catalase suppresses production of reactive
oxygen species (ROS) in a dose dependant pattern. Complete
suppression is observed at 50 unit/mL of catalase. The antioxi-
dant effect of this concentration is compatible with 40 mM of N-
acetyl-cysteine or 5 mM of glutathione. a or b denotes statistical
differences (p<0.01) in comparison with control or PQ group, re-
spectively.
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Fig. 3. Effect of N-acetyl-cysteine (NAC) and glutathione (GSH) on
the production of reactive oxygen species (ROS) by paraquat (PQ)
in Swiss 3T3: the signal intensities in Figure 2 were quantified by
a quantification software. 5-40 mM of NAC or 1-10 mM of GSH sup-
press ROS in a dose dependant pattern. Complete suppression of
ROS is observed at 40 mM of NAC or 5 mM of GSH. a or b
denotes statistical differences (p<0.01) in comparison with control
or PQ group, respectively.
R
O
S
 
(
f
o
l
d
)
NAC (mM) GSH (mM)
3.0
2.5
2.0
1.5
1.0
0.5
0.0 C PQ 5 20 40 1 2 5 10
a
a, b
a, b
a, b
a, b
b
a
b
Fig. 2. Production of reactive oxygen species (ROS) by paraquat treatment in a dose-dependent manner in Swiss 3T3: After 40 min incubation
of the cells with 20-500  M paraquat, intracellular ROS generation was assessed with 2,7-dichlorofluorescein and a laser scanning confocal
microscope (×400).
control 20 M 50 M
100 M 200 M 500 Mmost commonly used and specific indication is the presence
of oxidizing molecules. Direct detection of excited species is
possible by measurement of organ chemiluminescence. Also,
evidence that antioxidant defenses are functioning can indi-
cate the presence of oxidant stress. In our study, intracellular
ROS was measured by DCF fluorescence intensity. By mea-
suring the TAS, we could assess the change of the antioxi-
dant status of the plasma. The principle of measurement in
this assay system is quenching of a given radical cation. TAS
in plasma is influenced by several substances, such as urea,
thiol, vitamin C, and vitamin E, which is why we measured
the effect of free-radical scavengers on TAS in NPP.
In our study, both NAC and GSH had dual antioxidant
effects on intracellular and plasma ROS. NAC and GSH were
effective on ROS in plasma at concentrations of 5-40 mM.
When the target was intracellular ROS, the effective concen-
trations were 5-40 mM for NAC and 1-5 mM for GSH. Fur-
ther pharmacokinetic study is necessary to identify a safe load-
ing and maintenance dose of NAC and GSH for patients with
paraquat poisoning. When administered at the same concen-
trations, GSH was a stronger antioxidant than NAC in NPP.
In the same way, intracellular ROS was completely suppressed
when using 40 mM NAC and 5 mM GSH, and these concen-
trations are comparable with 50 unit/mL of catalase. This find-
ing suggests that GSH is a suitable treatment for patients with
paraquat poisoning. However, other biologic roles of NAC
have been reported, such as downregulation of the expression
of transcription factor NF- B, which is a major mediator of
inflammatory responses and controls expression of a large vari-
ety of genes encoding cytokines, growth factors, acute phase
proteins, and cell adhesion and immune-regulation molecules
(25). It also has been reported to reduce the plasma concentra-
tion of homocysteine and improve endothelial function. There-
fore, it seems reasonable to assume that both GSH and NAC
can be prescribed for patients with acute paraquat poisoning.
Our results raise some questions about the transport action
of NAC and GSH through the cell membrane. Several amino
acid transporters have been identified during the past decade,
such as heteromeric amino acid transporters (26). Griffith and
Meister (27) and Meister and Larsson (28) have reported that
GSH is exported in the plasma to various cells and organs,
and that it functions in the inter- and intra-organ transfer of
cysteine as part of a pathway for membrane transportation of
cysteine, cystine, and probably other amino acids (28).
Furthermore, there are evidences (15, 16) that endogenous
GSH can be taken up by cells and protect against paraquat
toxicity. Meanwhile, Smith et al. (29) have reported that in
vivo administration of GSH is hindered by its inability to
cross cell membranes and by rapid hydrolysis.
In our study, a slight increase in the concentrations of GSH
and catalase, but not of SOD, in culture media suppressed
intracellular ROS significantly. These findings demonstrate
that GSH and catalase entered the cell with the same ease as
does NAC.
In conclusion, both NAC and GSH were effective antioxi-
dants for not only ROS in plasma but also intracellular ROS
produced by paraquat. Intracellular ROS induced by exposure
to 500 mM paraquat for 40 min were completely suppressed
by 40 mM NAC and 5 mM GSH, and these concentrations
are comparable with 50 unit/mL of catalase. In order to main-
tain these effective concentrations in plasma, further pharma-
cokinetic investigations are necessary to define the loading
and maintenance dose of GSH and catalase.
ACKNOWLEDGEMENTS 
This study was supported by a grant (no. 02-PJ1-PG3-
20599-0005) from the Korea Health 21 R&D Project, Min-
istry of Health and Welfare, Republic of Korea.
REFERENCES
1. Berry DJ, Grove J. The determination of paraquat (1,1′ -dimethyl-4,
4′ -bipyridylium cation) in urine. Clin Chim Acta 1971; 34: 5-11.
2. Hong SY, Yang DH, Hwang KY. Associations between laboratory
parameters and outcome of paraquat poisoning. Toxicol Lett 2000;
118: 53-9.
3. Vale JA, Meredith TJ, Buckley BM. Paraquat poisoning: clinical fea-
tures and immediate general management. Hum Toxicol 1987; 6: 41-7.
4. Smith LL. Mechanism of paraquat toxicology in lung and its relevance
to treatment. Hum Toxicol 1987; 6: 31-6.
5. Yasaka T, Okudaira K, Fujito H, Matsumoto J, Ohya I, Miyamoto Y.
Further studies of lipid peroxidation in human paraquat poisoning.
Arch Intern Med 1986; 146: 681-5.
6. Lock EA, Wilks MF. Paraquat. In: Robert K, editor, Handbook of
pesticide toxicology. California: Academic Press 2001; 1559-603.
7. Meredith TJ, Vale JA. Treatment of paraquat poisoning in man: meth-
ods to prevent absorption. Hum Toxicol 1987; 6: 49-55.
8. Okonek S. Hemoperfusion in toxicology. Basic considerations of its
effectiveness. Clin Toxicol 1981; 18: 1185-98.
9. Proudfoot AT, Prescott LF, Jarvie DR. Haemodialysis for paraquat
poisoning. Hum Toxicol 1987; 6: 69-74.
10. Lock EA, Smith LL, Rose MS. Inhibition of paraquat accumulation
in rat lung slices by a component of rat plasma and a variety of drugs
and endogenous amines. Biochem Pharmacol 1976; 25: 1769-72.
11. Petry TW, Wolfgang GH, Jolly RA, Ochoa R, Donarski WJ. Antiox-
idant-dependent inhibition of diquat-induced toxicity in vivo. Toxicol-
ogy 1992; 74: 33-43.
12. Lin JL, Leu ML, Liu YC, Chen GH. A prospective clinical trial of
pulse therapy with glucocorticoid and cyclophosphamide in moderate
to severe paraquat-poisoned patients. Am J Respir Crit Care Med
1999; 159: 357-60.
13. Suntres ZE. Role of antioxidants in paraquat toxicity. Toxicology 2002;
180: 65-77.
14. Bus JS, Cagen SZ, Olgaard M, Gibson JE. A mechanism of paraquat
toxicity in mice and rats. Toxicol Appl Pharmacol 1976; 35: 501-13.
Antioxidants in Paraquat Poisoning 65315. Hagen TM, Brown LA, Jones DP. Protection against paraquat-indu-
ced injury by exogenous GSH in pulmonary alveolar type II cells.
Biochem Pharmacol 1986; 35: 4537-42.
16. Brown LA, Bai C, Jones DP. Glutathione protection in alveolar type
II cells from fetal and neonatal rabbits. Am J Physiol 1992; 262: L305-
12.
17. Cheng WH, Ho YS, Valentine BA, Ross DA, Combs GF Jr, Lei XG.
Cellular glutathione peroxidase is the mediator of body selenium to
protect against paraquat lethality in transgenic mice. J Nutr 1998;
128: 1070-6.
18. Jaeschke H, Mitchell JR. Use of isolated perfused organs in hypoxia
and ischemia/reperfusion oxidant stress. In: Packer L, Glazer AN,
editors, Oxygen radicals in biological systems. California: Academic
Press 1993; 752-66.
19. Hoffer E, Baum Y, Tabak A, Taitelman U. N-acetylcysteine increases
the glutathione content and protects rat alveolar type II cells against
paraquat-induced cytotoxicity. Toxicol Lett 1996; 84: 7-12.
20. Domenighetti G, Quattropani C, Schaller MD. Therapeutic use of N-
acetylcysteine in acute lung diseases. Rev Mal Respir 1999; 16: 29-37.
21. Kelly GS. Clinical applications of N-acetylcysteine. Altern Med Rev
1998; 3: 114-27.
22. Pizzulli L, Hagendorff A, Zirbes M, Jung W, Luderitz B. N-acetylcys-
teine attenuates nitroglycerin tolerance in patients with angina pectoris
and normal left ventricular function. Am J Cardiol 1997; 79: 28-33.
23. Duthie GG. Determination of activity of antioxidants in human sub-
jects. Proc Nutr Soc 1999; 58: 1015-24.
24. Koo HY, Shin I, Lee ZW, Lee SH, Kim SH, Lee CH, Kang HS, Ha
KS. Roles of RhoA and phospholipase A2 in the elevation of intracellu-
lar H2O2 by transforming growth factor- in Swiss 3T3 fibroblasts.
Cell Signal 1999; 11: 677-83.
25. Pajonk F, Riess K, Sommer A, McBride WH. N-acetyl-L-cysteine
inhibits 26S proteasome function: implications for effects on NF-kB
activation. Free Radic Biol Med 2002; 32: 536-43.
26. Wagner CA, Lang F, Broer S. Function and structure of heterodimeric
amino acid transporters. Am J Physiol Cell Physiol 2001; 281: C1077-
93.
27. Griffith OW, Meister A. Glutathione: interorgan translocation,
turnover, and metabolism. Proc Natl Acad Sci USA 1979; 76: 5606-10.
28. Meister A, Larsson A. Glutathione synthetase deficiency and other
disorders of the gamma-glutamyl cycle. In: Scriver CR, Beaudet AL,
Sly WS, Valle D, editors, The metabolic basis of inherited disease. New
York: McGraw-Hill 1989; 855-68.
29. Smith LJ, Anderson J, Shamsuddin M. Glutathione localization and
distribution after intratracheal instillation. Implications for treatment.
Am Rev Respir Dis 1992; 145: 153-9.
654 S.-Y. Hong, J.-O. Yang, E.-Y. Lee, et al.